Literature DB >> 30860861

Immunotherapy in Non-Small Cell Lung Cancer. Which Patients and at Which Stage?

James P Allinson1,2, James Brown1, Kate Gibb1, Neal Navani1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30860861     DOI： 10.1164/rccm.201810-1930RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.

Authors:  Rirong Qu; Fan Ye; Shaojie Hu; Boyu Wang; Shenghui Qin; Jing Xiong; Xiangning Fu; Lequn Li; Yixin Cai
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-20       Impact factor: 4.322

2.  Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.

Authors:  Kezhong Chen; Jing Bai; Alexandre Reuben; Heng Zhao; Guannan Kang; Chunliu Zhang; Qingyi Qi; Yaping Xu; Shawna Hubert; Lianpeng Chang; Yanfang Guan; Lin Feng; Kai Zhang; Kaitai Zhang; Xin Yi; Xuefeng Xia; Shujun Cheng; Fan Yang; Jianjun Zhang; Jun Wang
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.